Latest Articles

Publication Date
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally

GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally

Published: Feb. 18, 2026, noon
This surgery could slash the risk of the deadliest female cancer by almost 80% - SMH.com.au

This surgery could slash the risk of the deadliest female cancer by almost 80% SMH.com.au

Published: Feb. 18, 2026, 8 a.m.
Risk factors and prediction models for pain after endometriosis-related surgery-what do we (not) know yet.

Published: Feb. 18, 2026, midnight
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues

Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues

Published: Feb. 17, 2026, 3:15 p.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine

Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine

Published: Feb. 17, 2026, 12:15 a.m.
The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.

Letrozole and other aromatase inhibitors are increasingly recognized as first-line ovulation induction (OI) medications, offering an efficient and physiologic approach to ovarian stimulation that enhances outcomes in reproductive medicine. By …

Published: Feb. 17, 2026, midnight
Association Between Body Fat Percentage and Endometriosis Severity Based on American Association of Gynecologic Laparoscopists 2021 Endometriosis Classification.

Endometriosis is one of the main reproductive issues that the modifiable risk factors is still the main research focus. It is still unclear how various adiposity affect the onset and …

Published: Feb. 17, 2026, midnight
A Dive into the Invisible: The Vaginal and Endometrial Microbiota in Gynecologic and Obstetric Disorders: A Narrative Review.

The human microbiota is increasingly recognized as a key component of women's reproductive health. This narrative review examines the vaginal, endometrial, and gut microbiota and their roles in the pathogenesis …

Published: Feb. 17, 2026, midnight
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com

Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com

Published: Feb. 16, 2026, 10:55 a.m.
Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk - geneonline.com

Study Finds GLP-1 Medications Combined with Progestin Therapy May Lower Endometrial Cancer Risk geneonline.com

Published: Feb. 16, 2026, 6:10 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!